Bevirimat
CAS No. 174022-42-5
Bevirimat( PA-457 | MPC-4326 | YK FH312 )
Catalog No. M20655 CAS No. 174022-42-5
Bevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 87 | In Stock |
|
10MG | 147 | In Stock |
|
25MG | 327 | In Stock |
|
50MG | 484 | In Stock |
|
100MG | 691 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBevirimat
-
NoteResearch use only, not for human use.
-
Brief DescriptionBevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.
-
DescriptionBevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.
-
In Vitro——
-
In Vivo——
-
SynonymsPA-457 | MPC-4326 | YK FH312
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1
-
Research AreaInfection
-
IndicationHIV-1 Infection
Chemical Information
-
CAS Number174022-42-5
-
Formula Weight584.83
-
Molecular FormulaC36H56O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (85.49 mM)
-
SMILES[H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O)C(C)=C
-
Chemical Name(1R3aS5aR5bR7aR9S11aR11bR13aR13bR)-9-((3-carboxy-3-methylbutanoyl)oxy)-5a5b8811a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Smith P F Ogundele A Forrest A et al. Phase I and II Study of the Safety Virologic Effect and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-O-(3′3′-Dimethylsuccinyl)Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection[J]. Antimicrobial Agents & Chemotherapy 2007 51(10):3574.
molnova catalog
related products
-
BI 224436
BI 224436 is a potent, specific, noncatalytic site integrase inhibitor (NCINI) of HIV-1 with EC50 of 11-27 nM against different HIV-1 laboratory strains.
-
IMB-301
IMB-301 (NSC 301209) is a small molecule inhibitor that target the binding interface of the HIV-1 Vif/hA3G complex.
-
Etravirine
A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.